Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthis Synofzik

Showing results (1-10 of 511) with videos related to

Pageof 52
Sort By:
The Virtual Mentor : VM|December 20, 2012
Measuring the immeasurable? Quality of life and medical decision makingMatthis Synofzik
International Review of Neurobiology|November 30, 2019
Parkinsonism in neurodegenerative diseases predominantly presenting with ataxiaMatthis Synofzik
Zeitschrift Fur Gerontologie Und Geriatrie|August 11, 2006
[Effective, indicated--and yet without benefit? The goals of dementia drug treatment and the well-being of the patient]Matthis Synofzik
Ethik in Der Medizin : Organ Der Akademie Fur Ethik in Der Medizin|December 13, 2006
[Cognition on demand?--The wish for cognition-enhancing drugs in medicine]Matthis Synofzik
Consciousness and Cognition|February 4, 2012
Beyond the comparator modelMatthis Synofzik, Gottfried Vosgerau
Cerebellum (London, England)|April 5, 2023
Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert GuidanceThomas Klockgether, Matthis Synofzik,
Frontiers in Human Neuroscience|August 28, 2014
Affective coding: the emotional dimension of agencyAntje Gentsch, Matthis Synofzik
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2017
Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathwaysMatthis Synofzik, Rebecca Schüle
Journal of Neurochemistry|October 11, 2016
New transgenic ALS/FTD models on the rat-walk: An Editorial Highlight for 'Increased Ubqln2 expression causes neuron death in transgenic rats'Judith Stegmüller, Matthis Synofzik
Movement Disorders Clinical Practice|February 5, 2019
Moving Beyond Syndromic Classifications in Neurodegenerative Disease: The Example of PLA2G6Matthis Synofzik, Thomas Gasser
Pageof 52

Showing results (1-10 of 511) with videos related to

Sort By:
Pageof 52
The Virtual Mentor : VM|December 20, 2012
Measuring the immeasurable? Quality of life and medical decision makingMatthis Synofzik
International Review of Neurobiology|November 30, 2019
Parkinsonism in neurodegenerative diseases predominantly presenting with ataxiaMatthis Synofzik
Zeitschrift Fur Gerontologie Und Geriatrie|August 11, 2006
[Effective, indicated--and yet without benefit? The goals of dementia drug treatment and the well-being of the patient]Matthis Synofzik
Ethik in Der Medizin : Organ Der Akademie Fur Ethik in Der Medizin|December 13, 2006
[Cognition on demand?--The wish for cognition-enhancing drugs in medicine]Matthis Synofzik
Consciousness and Cognition|February 4, 2012
Beyond the comparator modelMatthis Synofzik, Gottfried Vosgerau
Cerebellum (London, England)|April 5, 2023
Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert GuidanceThomas Klockgether, Matthis Synofzik,
Frontiers in Human Neuroscience|August 28, 2014
Affective coding: the emotional dimension of agencyAntje Gentsch, Matthis Synofzik
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2017
Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathwaysMatthis Synofzik, Rebecca Schüle
Journal of Neurochemistry|October 11, 2016
New transgenic ALS/FTD models on the rat-walk: An Editorial Highlight for 'Increased Ubqln2 expression causes neuron death in transgenic rats'Judith Stegmüller, Matthis Synofzik
Movement Disorders Clinical Practice|February 5, 2019
Moving Beyond Syndromic Classifications in Neurodegenerative Disease: The Example of PLA2G6Matthis Synofzik, Thomas Gasser
Pageof 52